Abdulmaged Traish | Profiles RNS

Abdulmaged M. Traish, PhD

Professor Emeritus

Boston University Chobanian & Avedisian School of Medicine

Urology

PhD, Boston University
BS, University of Tripoli

Websites

	Sexual Medicine Faculty
	The Androgen Study Group
	ResearchGate
	Androgen Society

ORCID : 0000-0003-3850-0329

Abdulmaged Traish is Emeritus Professor of Urology at Chobanian and Avedisian School of Medicine. He earned a B.Sc., in Chemistry & Botany form the University of Tripoli, Tripoli, LIBYA in 1971 and a Ph.D., in Biochemistry from Boston University, Boston, MA in 1978. After two years of training as a postdoctoral Fellowship in the Department of Biochemistry at Chobanian and Avedisian School of Medicine, he was appointed as an assistant research professor of Biochemistry in the Department of Biochemistry. Professor Traish also earned Master of Business Administration (MBA) from Boston University School of Management in 1993.

Over the past three decades, Dr. Traish has contributed significantly, through teaching, education and basic research, to the field of biochemistry and physiology of reproductive and sexual medicine. His most important contributions to the field of sexual medicine are the development of experimental animal models to investigate the endocrine regulation of sexual arousal physiology and function in males and females and his pioneering work on the basic mechanisms of sex steroid hormones on erectile physiology. Professor Traish has been successful in procuring research funds from the National Institute of Health as well as from the Private Sector and was instrumental in the establishment of the institute for sexual medicine at Chobanian and Avedisian School of Medicine.

Professor Traish had served as an advisor/mentor for more than 48 students who earned a Master of Arts in Medical Sciences degree and was a reader on their thesis dissertation. He also mentored 5 doctoral students (Ph.D.) who completed their research dissertation in his laboratory. Professor Traish has advised and served as mentor for physician-scientists, medical residents and research fellows from several countries including Italy, South Korea, Turkey, Greece and the USA, who sought research training in his laboratory.

Professor Traish has authored and co-authored over 185 original research publications and several book chapters and co-edited one of the first books on female sexual function and dysfunction. Dr. Traish’ research lead to several inventions including seven patents, approved by the USA Department of Patent Office.

As an outstanding teacher, Professor Traish was awarded the Educator of the Year award by Council on Faculty Affairs Award for Excellence in Teaching in Graduate Sciences, in 2000 and once again in 2004. In 2006, Professor Traish was awarded the highest Teaching Award given by Boston University to an outstanding professor for teaching “The Metcalf Prize & Cup for Teaching Excellence”. As an outstanding researcher and pioneer in field of sexual medicine, Dr. Traish delivered more than 90 lectures on his research in various National and International conferences, congresses and Universities in the US, Europe, Asia, Africa and Latin America.

Professor Traish is the Research Director of The Institute for Sexual Medicine at Chobanian and Avedisian School of Medicine. He served as a member of the Medical School Curriculum Committee, the Grading Committee, the Department of Biochemistry Admissions Committee, the Medical school Admissions Committee, a Member of the Medical School Academies, Chaired the Graduate Medical Sciences Program Advising Committee and is a member of the Advisory Group for BU-Works Committee. Dr. Traish serves on the editorial boards of several Journals and an ad hoc reviewer for many journals in his field.

Professor Emeritus
Boston Medical Center

Graduate Faculty (Primary Mentor of Grad Students)
Boston University Chobanian & Avedisian School of Medicine, Graduate Medical Sciences

BU Research
NIH RePORTER Research

Unrestricted Educational Research Grant
07/01/2005 - 12/31/2007 (PI)
Schering AG (Germany)

Study to Characterize the Effects of Testosterone on the Cavernosal Nerve Structure Using Light and Electron Microscopy
07/20/2006 - 07/19/2007 (PI)
Auxilium Pharmaceuticals, Inc.

In Vivo Assessment of EP2/EP4 Agonists (Serono) in Facilitating Male and Female Sexual Function
12/23/2002 - 06/30/2006 (PI)
Serono Inc

Female Sexual Arousal: Clitoral and Vaginal Physiology
09/15/2000 - 06/30/2005 (PI)
NIH/National Diabetes & Digestive & Kidney Diseases
5 R01 DK56846 04

Modulation of Erectile Physiology by Androgens & Phosphodiesterase Type 5 Inhibitor, Sildernafil
12/15/2002 - 06/30/2004 (PI)
Pfizer, Inc.

The Effects of Intravaginal Administration of Rec 15/2615 Formulation on Genital Blood Flow
09/01/2002 - 08/31/2003 (PI)
Recordati Industria Chimica E Farmaceutica S.p.A. (Italy)

In Vivo Modulation of Vaginal Smooth Muscle Tone and Genital Blood Flow by the Alpha I Antagonist (SH-19991012)
07/01/2001 - 06/30/2002 (PI)
Molecular Design International, Inc

Effects of Estrogen and Androgen Deprivation and Replacement Therapy on Sildenafil Augmentation of Pelvic Nerve-Medicated Female Genital
12/15/2000 - 12/14/2001 (PI)
Pfizer, Inc.

Potential Role of a Novel Nuclear Matrix Protein (nmt55) as a Tumor Marker in Human Breast Cancer Invasion and Metastases
07/01/1998 - 06/30/2001 (Dept Sponsor)
Department of Defense/Army

Effects of P2 & 2 Agonist INS365 and INS45973 on Vaginal Mucosal Health in Oophoectomized Rabbits
09/08/2000 - 06/08/2001 (PI)
Inspire Pharmaceuticals Inc

Showing 10 of 12 results. Show All Results

Title

Yr	Title	Project-Sub Proj	Pubs
2003	FEMALE SEXUAL AROUSAL: CLITORAL AND VAGINAL PHYSIOLOGY	5R01DK056846-04	31
2002	FEMALE SEXUAL AROUSAL: CLITORAL AND VAGINAL PHYSIOLOGY	5R01DK056846-03	31
2001	FEMALE SEXUAL AROUSAL: CLITORAL AND VAGINAL PHYSIOLOGY	5R01DK056846-02	31
2000	FEMALE SEXUAL AROUSAL: CLITORAL AND VAGINAL PHYSIOLOGY	1R01DK056846-01A1	31
1997	NEUROTRANSMITTER RECEPTORS IN ERECTILE TISSUE	5R01DK040025-09	59
1996	NEUROTRANSMITTER RECEPTORS IN ERECTILE TISSUE	5R01DK040025-08	59
1995	ENDOTHELIUM AND PENILE ERECTION	5R01DK040487-08	48
1995	NEUROTRANSMITTER RECEPTORS IN ERECTILE TISSUE	2R01DK040025-07	59
1994	NEUROTRANSMITTER RECEPTORS IN ERECTILE TISSUE	5R01DK040025-06	59
1993	NEUROTRANSMITTERS RECEPTORS IN ERECTILE TISSUE	5R01DK040025-05	59

Showing 10 of 11 results. Show All Results

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis Copy PMIDs To Clipboard

Traish AM. Major cardiovascular disease risk in men with testosterone deficiency (hypogonadism): appraisal of short, medium and long-term testosterone therapy - a narrative review. Sex Med Rev. 2023 Sep 27; 11(4):384-394. PMID: 37587664

Morgentaler A, Traish A, Barua RS, Dandona P, Dhindsa S, Khera M, Saad F. Recognizing the True Value of Testosterone Therapy in Health Care. Androg Clin Res Ther. 2022; 3(1):217-223. PMID: 36643964; PMCID: PMC9814113; DOI: 10.1089/andro.2022.0021;

Traish AM. Sex steroids and COVID-19 mortality in women. Trends Endocrinol Metab. 2021 08; 32(8):533-536. PMID: 33966962; PMCID: PMC8055185; DOI: 10.1016/j.tem.2021.04.006;

Parish SJ, Simon JA, Davis SR, Giraldi A, Goldstein I, Goldstein SW, Kim NN, Kingsberg SA, Morgentaler A, Nappi RE, Park K, Stuenkel CA, Traish AM, Vignozzi L. International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women. J Sex Med. 2021 05; 18(5):849-867. PMID: 33814355

Haider KS, Haider A, Saad F, Doros G, Hanefeld M, Dhindsa S, Dandona P, Traish A. Remission of type 2 diabetes following long-term treatment with injectable testosterone undecanoate in patients with hypogonadism and type 2 diabetes: 11-year data from a real-world registry study. Diabetes Obes Metab. 2020 11; 22(11):2055-2068.View Related Profiles.

Traish, Abdulmaged
Doros, Gheorghe

PMID: 32558149; PMCID: PMC7689919; DOI: 10.1111/dom.14122;

Morgentaler A, Traish AM. Letter to the editor: Questioning the evidence behind the Saturation Model for testosterone replacement therapy in prostate cancer. Investig Clin Urol. 2020 07; 61(4):452-454. PMID: 32666003; PMCID: PMC7329646; DOI: 10.4111/icu.2020.61.4.452;

Traish AM. Health Risks Associated with Long-Term Finasteride and Dutasteride Use: It's Time to Sound the Alarm. World J Mens Health. 2020 Jul; 38(3):323-337. PMID: 32202088; PMCID: PMC7308241; DOI: 10.5534/wjmh.200012;

Traish AM. Post-finasteride syndrome: a surmountable challenge for clinicians. Fertil Steril. 2020 01; 113(1):21-50. PMID: 32033719

Showing 10 of 336 results. Show More

Morgentaler A, Traish AM, Khera M. A Critique of the AUA Guidelines on Testosterone Deficiency. J Sex Med. 2020 04; 17(4):561-564. PMID: 31812687

Shlykova N, Davidson E, Krakowsky Y, Bolanos J, Traish A, Morgentaler A. Absent Diurnal Variation in Serum Testosterone in Young Men with Testosterone Deficiency. J Urol. 2020 04; 203(4):817-823. PMID: 31670607

Traish AM, Hackett G, Miner M, Morgentaler A. Cardiovascular and Cerebrovascular Safety of Testosterone Therapy. Am J Med. 2019 10; 132(10):e748. PMID: 31648787

Morgentaler A, Traish A, Hackett G, Jones TH, Ramasamy R. Diagnosis and Treatment of Testosterone Deficiency: Updated Recommendations From the Lisbon 2018 International Consultation for Sexual Medicine. Sex Med Rev. 2019 10; 7(4):636-649. PMID: 31351915

Traish A, Bolanos J, Nair S, Saad F, Morgentaler A. Do Androgens Modulate the Pathophysiological Pathways of Inflammation? Appraising the Contemporary Evidence. J Clin Med. 2018 Dec 14; 7(12). PMID: 30558178; PMCID: PMC6306858; DOI: 10.3390/jcm7120549;

Traish AM, Krakowsky Y, Doros G, Morgentaler A. Do 5a-Reductase Inhibitors Raise Circulating Serum Testosterone Levels? A Comprehensive Review and Meta-Analysis to Explaining Paradoxical Results. Sex Med Rev. 2019 01; 7(1):95-114.View Related Profiles.

Traish, Abdulmaged
Doros, Gheorghe

PMID: 30098986

Traish AM, Johansen V. Impact of Testosterone Deficiency and Testosterone Therapy on Lower Urinary Tract Symptoms in Men with Metabolic Syndrome. World J Mens Health. 2018 Sep; 36(3):199-222. PMID: 30079638; PMCID: PMC6119850; DOI: 10.5534/wjmh.180032;

Simon JA, Goldstein I, Kim NN, Davis SR, Kellogg-Spadt S, Lowenstein L, Pinkerton JV, Stuenkel CA, Traish AM, Archer DF, Bachmann G, Goldstein AT, Nappi RE, Vignozzi L. The role of androgens in the treatment of genitourinary syndrome of menopause (GSM): International Society for the Study of Women's Sexual Health (ISSWSH) expert consensus panel review. Menopause. 2018 07; 25(7):837-847. PMID: 29870471

Miner M, Morgentaler A, Khera M, Traish AM. The state of testosterone therapy since the FDA's 2015 labelling changes: Indications and cardiovascular risk. Clin Endocrinol (Oxf). 2018 07; 89(1):3-10. PMID: 29486065

Morgentaler A, Traish A. The History of Testosterone and the Evolution of its Therapeutic Potential. Sex Med Rev. 2020 Apr; 8(2):286-296. PMID: 29661690

Traish AM, Vignozzi L, Simon JA, Goldstein I, Kim NN. Role of Androgens in Female Genitourinary Tissue Structure and Function: Implications in the Genitourinary Syndrome of Menopause. Sex Med Rev. 2018 10; 6(4):558-571. PMID: 29631981

Saad F, Haider A, Sultan Haider K, Doros G, Traish AM. 097 In obese hypogonadal men, long-term testosterone therapy improves erectile function, quality of life and body weight – real-life evidence from a registry study. Journal of Sexual Medicine. 2018; 15(7):S168-S169. View Publication
Saad F, Sultan Haider K, Doros G, Traish AM, Haider A. 099 Erectile function improves in hypogonadal men with type 2 diabetes under long-term testosterone therapy: real-world evidence from a urological registry study. Journal of Sexual Medicine. 2018; 15(7):S169-S170. View Publication
Traish AM, Krakowsky Y, Doros G, Morgentaler A. Do 5a-Reductase Inhibitors Raise Circulating Serum Testosterone Levels? A Comprehensive Review and Meta-Analysis to Explaining Paradoxical Results. 2018. View Publication
Saad F, Sultan Haider K, Haider A, Doros G, Traish AM. 090 Reduction of major adverse cardiovascular events (MACE) and improvement of erectile function in hypogonadal men receiving testosterone therapy – real-life evidence from a registry study. Journal of Sexual Medicine. 2018; 15(7):S164-S165. View Publication
Sultan Haider K, Haider A, Doros G, Traish A. Urinary function improves in hypogonadal men with moderate International Prostate Symptom Score (IPSS) treated for up to 10 years with testosterone in comparison to untreated controls. European Urology Supplements. 2018; 17(2):e1543. View Publication
Traish AM. The Post-finasteride Syndrome: Clinical Manifestation of Drug-Induced Epigenetics Due to Endocrine Disruption. Current Sexual Health Reports. 2018. View Publication
Sultan Haider K, Haider A, Doros G, Traish AM. PD26-10 URINARY FUNCTION IN 776 HYPOGONADAL MEN WITH MILD OR MODERATE IPPS WITH AND WITHOUT TESTOSTERONE THERAPY FOR UP TO 10 YEARS. The Journal of Urology. 2018; 199(4):e555-e556. View Publication

Traish AM. Benefits and Health Implications of Testosterone Therapy in Men With Testosterone Deficiency. Sex Med Rev. 2018 01; 6(1):86-105. PMID: 29128268

Haider KS, Haider A, Doros G, Traish A. Long-Term Testosterone Therapy Improves Urinary and Sexual Function, and Quality of Life in Men with Hypogonadism: Results from a Propensity Matched Subgroup of a Controlled Registry Study. J Urol. 2018 01; 199(1):257-265.View Related Profiles.

Traish, Abdulmaged
Doros, Gheorghe

PMID: 28728990

Traish A, Haider KS, Doros G, Haider A. Long-term dutasteride therapy in men with benign prostatic hyperplasia alters glucose and lipid profiles and increases severity of erectile dysfunction. Horm Mol Biol Clin Investig. 2017 Jun 21; 30(3).View Related Profiles.

Traish, Abdulmaged
Doros, Gheorghe

PMID: 28632494

Traish AM, Haider A, Haider KS, Doros G, Saad F. Long-Term Testosterone Therapy Improves Cardiometabolic Function and Reduces Risk of Cardiovascular Disease in Men with Hypogonadism: A Real-Life Observational Registry Study Setting Comparing Treated and Untreated (Control) Groups. J Cardiovasc Pharmacol Ther. 2017 Sep; 22(5):414-433.View Related Profiles.

Traish, Abdulmaged
Doros, Gheorghe

PMID: 28421834; PMCID: PMC5555449; DOI: 10.1177/1074248417691136;

Saad F, Haider A, Haider KS, Doros G, Traish A. 130 Long-term Testosterone Treatment Improves Glycemic Control in Hypogonadal Men - Results from a Propensity-matched Subgroup of a Controlled Registry Study. Journal of Sexual Medicine. 2017; 14(2):e51-e52. View Publication

Traish AM. Negative Impact of Testosterone Deficiency and 5a-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men. Adv Exp Med Biol. 2017; 1043:473-526. PMID: 29224108

Zitzmann M, Rohayem J, Cremers JF, Kliesch S, Traish AM. MP91-07 LONGTERM TREATMENT OF HYPOGONADAL MEN: RESULTS FROM A 9-YEAR-REGISTRY. The Journal of Urology. 2017; 197(4):e1220-e1221. View Publication
Yassin A, Yassin DJ, Doros G, Traish AM. PD45-03 VOIDING FUNCTION IMPROVES UNDER LONG-TERM TREATMENT WITH TESTOSTERONE UNDECANOATE INJECTIONS (TU) IN HYPOGONADAL MEN FOR UP TO 12 YEARS INDEPENDENT OF PROSTATE SIZE. The Journal of Urology. 2017; 197(4):e885-e886. View Publication
Yassin A, Yassin DJ, Doros G, Traish AM. MP91-11 POSITIVE EFFECTS OF LONG-TERM TREATMENT WITH TESTOSTERONE UNDECANOATE INJECTIONS (TU) ON RENAL FUNCTION IN HYPOGONADAL MEN: REAL-LIFE DATA FROM A PROSPECTIVE CONTROLLED REGISTRY STUDY. The Journal of Urology. 2017; 197(4):e1222. View Publication
Haider A, Haider KS, Doros G, Traish AM. MP91-12 ERECTILE FUNCTION IN 656 HYPOGONADAL MEN IMPROVES OVER 8 YEARS WITH TESTOSTERONE UNDECANOATE INJECTIONS (TU) IN COMPARISON TO AN UNTREATED CONTROL GROUP. The Journal of Urology. 2017; 197(4):e1222. View Publication
Haider K, Haider A, Doros G, Traish AM. 005 Erectile Function in 164 Matched Hypogonadal Men: Results of Long Term Treatment With Testosterone Undecanoate Injections (TU) in Comparison With Control Group. Journal of Sexual Medicine. 2017; 14(1):S3. View Publication
Saad F, Doros G, Haider A, Haider KS, Traish AM. HP-03-002 Erectile function in 164 propensity-matched hypogonadal men from a registry with or without treatment with testosterone undecanoate injections (TU) for up to 8 years. Journal of Sexual Medicine. 2017; 14(4):e147. View Publication
Haider A, Haider KS, Doros G, Traish AM. Testosterone therapy (TTh) improves urinary function and reduces major adverse cardiovascular events (MACE) in hypogonadal men with type 2 diabetes (T2DM) treated up to 8 years in comparison to an untreated control group. European Urology Supplements. 2017; 16(3):e934. View Publication
Saad F, Haider A, Sultan Haider K, Doros G, Traish AM. P6203Major adverse cardiovascular events (MACE) are reduced in testosterone-treated vs. untreated hypogonadal men: real-life evidence from a controlled registry study. European Heart Journal. 2017; 38(suppl 1). View Publication
Saad F, Doros G, Haider A, Traish A. PS-08-010 Improvement of erectile function in 225 hypogonadal men with type 2 diabetes (T2DM) over 8 years with testosterone undecanoate injections (TU) in comparison to an untreated control group. Journal of Sexual Medicine. 2017; 14(4):e134. View Publication

Traish AM, Vance JC, Morgentaler A. Overselling hysteria: The role of the media and medical journals in promoting questionable risks-a case study of the testosterone controversy. EMBO Rep. 2017 01; 18(1):11-17. PMID: 27920032; PMCID: PMC5210128; DOI: 10.15252/embr.201643642;

Traish A. Erratum: Correction of the references for Figures. Testosterone therapy in men with testosterone deficiency: Are we beyond the point of no return? Investig Clin Urol. 2017 01; 58(1):77. PMID: 28097272; PMCID: PMC5240292; DOI: 10.4111/icu.2017.58.1.77;

Saad F, Röhrig G, von Haehling S, Traish A. Testosterone Deficiency and Testosterone Treatment in Older Men. Gerontology. 2017; 63(2):144-156. PMID: 27855417; DOI: 10.1159/000452499;

Traish A. Testosterone therapy in men with testosterone deficiency: Are we beyond the point of no return? Investig Clin Urol. 2016 Nov; 57(6):384-400. PMID: 27847912; PMCID: PMC5109795; DOI: 10.4111/icu.2016.57.6.384;

Traish AM. Testosterone therapy in men with testosterone deficiency: are the benefits and cardiovascular risks real or imagined? Am J Physiol Regul Integr Comp Physiol. 2016 Sep 01; 311(3):R566-73. PMID: 27488887; DOI: 10.1152/ajpregu.00174.2016;

Morgentaler A, Zitzmann M, Traish AM, Fox AW, Jones TH, Maggi M, Arver S, Aversa A, Chan JC, Dobs AS, Hackett GI, Hellstrom WJ, Lim P, Lunenfeld B, Mskhalaya G, Schulman CC, Torres LO. Fundamental Concepts Regarding Testosterone Deficiency and Treatment: International Expert Consensus Resolutions. Mayo Clin Proc. 2016 Jul; 91(7):881-96. PMID: 27313122; DOI: 10.1016/j.mayocp.2016.04.007;

Saad F, Doros G, Haider A, Traish AM. PS-08-011 77 men with pre-existing cardiovascular disease (CVD) and hypogonadism show improved erectile function on long-term treatment with testosterone undecanoate injections (TU). Journal of Sexual Medicine. 2016; 13(5):S114-S115. View Publication
Yassin A, Haider A, Sultan Haider K, Saad F. MP47-07 PREDIABETES, HYPOGONADISM & ERECTILE DYSFUNCTION: GLYCAEMIC CONTROL IN 109 HYPOGONADAL MEN TREATED WITH TESTOSTERONE UNDECANOATE INJECTIONS (TU) FOR UP TO 8 YEARS: REAL-LIFE DATA FROM REGISTRY STUDIES. The Journal of Urology. 2016; 195(4):e629. View Publication
Morgentaler A, Zitzmann M, Traish AM, Fox AW, Jones TH, Maggi M, Arver S, Aversa A, Chan JCN, Dobs AS, Hackett GI, Hellstrom WJG, Lim P, Lunenfeld B, Mskhalaya G, Schulman CC, Otavio Torres L. The consensus recommendations of a group of international experts on the fundamental concepts related to the issues of testosterone deficiency and its treatment. 2016. View Publication
Haider A, Sultan Haider K, Doros G, Traish AM. PD09-06 PROSTATE CANCER IS LESS FREQUENT AND SEVERE IN HYPOGONADAL MEN TREATED ADEQUATELY WITH TESTOSTERONE UNDECANOATE INJECTIONS (TU) FOR UP TO 8 YEARS COMPARED TO UNTREATED HYPOGONADAL CONTROLS. The Journal of Urology. 2016; 195(4):e236. View Publication
Saad F, Haider A, Sultan Haider K, Yassin A, Doros G, Traish A. HP-09-001 Erectile function and glycaemic control in 109 hypogonadal men with Prediabetes treated with testosterone undecanoate injections (TU) for up to 8 years: real-life data from registry studies. Journal of Sexual Medicine. 2016; 13(5):S139. View Publication

Morgentaler A, Zitzmann M, Traish AM, Fox A. International expert consensus conference on testosterone deficiency and its treatment held in Prague, Czech Republic. Aging Male. 2015; 18(4):205-6. PMID: 26586191; DOI: 10.3109/13685538.2015.1106469;

Traish AM, Zitzmann M. The complex and multifactorial relationship between testosterone deficiency (TD), obesity and vascular disease. Rev Endocr Metab Disord. 2015 Sep; 16(3):249-68. PMID: 26590935; DOI: 10.1007/s11154-015-9323-2;

Traish AM, Melcangi RC, Bortolato M, Garcia-Segura LM, Zitzmann M. Adverse effects of 5a-reductase inhibitors: What do we know, don't know, and need to know? Rev Endocr Metab Disord. 2015 Sep; 16(3):177-98. PMID: 26296373; DOI: 10.1007/s11154-015-9319-y;

Traish AM, Haider KS, Doros G, Haider A. Finasteride, not tamsulosin, increases severity of erectile dysfunction and decreases testosterone levels in men with benign prostatic hyperplasia. Horm Mol Biol Clin Investig. 2015 Sep; 23(3):85-96.View Related Profiles.

Traish, Abdulmaged
Doros, Gheorghe

PMID: 26053014; DOI: 10.1515/hmbci-2015-0015;

Morgentaler A, Miner MM, Caliber M, Guay AT, Khera M, Traish AM. Testosterone therapy and cardiovascular risk: advances and controversies. Mayo Clin Proc. 2015 Feb; 90(2):224-51. PMID: 25636998

Haider A, Haider KS, Doros G, Traish AM. PD45-03 LONG-TERM TREATMENT WITH TESTOSTERONE UNDECANOATE INJECTIONS SUSTAINABLY IMPROVES ERECTILE FUNCTION AND METABOLIC CONTROL IN HYPOGONADAL MEN WITH TYPE 2 DIABETES MELLITUS (T2DM). The Journal of Urology. 2015; 193(4):e903. View Publication
Saad F, Doros G, Haider A, Traish A. HYPOGONADAL MEN WITH PRE-EXISTING CARDIOVASCULAR DISEASE (CVD) SHOW IMPROVED ERECTILE FUNCTION ON LONG-TERM TREATMENT WITH TESTOSTERONE UNDECANOATE INJECTIONS. Journal of Sexual Medicine. 2015; 12:233.
Yassin A, Taleb R, Al Mehmadi Y, Doros G, Traish AM. 240 Long term testosterone treatment: Effects of therapy withdrawal and re-treatment in hypogonadal elderly men on obesity, voiding function and prostate safety parameters. How long should hypogonadal subjects be treated?. European Urology Supplements. 2015; 14(2):e240. View Publication
Saad F, Haider A, Yassin A, Doros G, Traish A. IMPROVEMENT OF METABOLIC SYNDROME (METS) PARAMETERS IN 362 OBESE HYPOGONADAL MEN UPON LONG-TERM TREATMENT WITH TESTOSTERONE UNDECANOATE (TU) INJECTIONS: OBSERVATIONAL DATA FROM TWO REGISTRY STUDIES. Journal of Sexual Medicine. 2015; 12:77.
Saad F, Doros G, Haider A, Traish AM. IMPROVEMENT AND STABILIZATION OF ERECTILE FUNCTION, ANTHROPOMETRIC AND METABOLIC PARAMETERS IN HYPOGONADAL MEN WITH TYPE 2 DIABETES MELLITUS (T2DM) ON LONG-TERM TREATMENT WITH TESTOSTERONE UNDECANOATE INJECTIONS. Journal of Sexual Medicine. 2015; 12:245-246.

Traish AM, Morgentaler A, Khera M. RE: Testosterone treatment is a potent tumor promoter for the rat prostate. Endocrinology. 2015 Jan; 156(1):L1-2. PMID: 25526553; DOI: 10.1210/en.2014-1843;

Saad F, Yassin A, Traish A. TEMPORARY WITHDRAWAL OF TESTOSTERONE TREATMENT IN MORBIDLY OBESE HYPOGONADAL MEN A SERIES OF CASE REPORTS. Journal of Sexual Medicine. 2015; 12:236.
Saad F, Haider A, Doros G, Traish AM. WEIGHT LOSS AND AND REDUCTION OF WAIST SIZE IN 237 HYPOGONADAL MEN WITH OBESITY GRADES I-III UNDER LONG-TERM TREATMENT WITH TESTOSTERONE UNDECANOATE (TU): OBSERVATIONAL DATA FROM A REGISTRY STUDY. Journal of Sexual Medicine. 2015; 12:53.
Haider A, Haider KS, Doros G, Traish AM. PD45-04 INCIDENCE OF PROSTATE CANCER AND EFFECTS ON PROSTATE-RELATED PARAMETERS UNDER LONG-TERM THERAPY WITH TESTOSTERONE UNDECANOATE INJECTIONS (TU) IN HYPOGONADAL MEN FOR UP TO 84 MONTHS: REAL-LIFE EXPERIENCE FROM AN OBSERVATIONAL REGISTRY STUDY. The Journal of Urology. 2015; 193(4):e903. View Publication
Traish AM. The Impact of the 5a-Reductase Inhibitors (5a-RIs) on Male Sexual Function and Psychological Well-Being. Current Sexual Health Reports. 2015; 7(4). View Publication
Saad F, Haider A, Yassin A, Doros G, Traish AM. Treatment of hypogonadal obese men with parenteral testosterone undecanoate induces weight loss, improves the metabolic syndrome, and in diabetics, improves metabolic control. Appetite. 2015; 87:399. View Publication

Traish AM, Guay AT, Zitzmann M. 5a-Reductase inhibitors alter steroid metabolism and may contribute to insulin resistance, diabetes, metabolic syndrome and vascular disease: a medical hypothesis. Horm Mol Biol Clin Investig. 2014 Dec; 20(3):73-80. PMID: 25460297; DOI: 10.1515/hmbci-2014-0025;

Garcia-Banigan D, Guay A, Traish A, Doros G, Gawoski J. In women, no significant variances of calculated free testosterone (cFT) are observed when a fixed value of albumin (Alb: 4.3 g/dL) is used instead of measured albumin values. Horm Mol Biol Clin Investig. 2014 Dec; 20(3):91-7.View Related Profiles.

Traish, Abdulmaged
Doros, Gheorghe

PMID: 25460298; DOI: 10.1515/hmbci-2014-0027;

Traish AM. Testosterone and weight loss: the evidence. Curr Opin Endocrinol Diabetes Obes. 2014 Oct; 21(5):313-22. PMID: 25105998; PMCID: PMC4154787; DOI: 10.1097/MED.0000000000000086;

Traish AM, Mulgaonkar A, Giordano N. The dark side of 5a-reductase inhibitors' therapy: sexual dysfunction, high Gleason grade prostate cancer and depression. Korean J Urol. 2014 Jun; 55(6):367-79. PMID: 24955220; PMCID: PMC4064044; DOI: 10.4111/kju.2014.55.6.367;

Traish AM. Adverse health effects of testosterone deficiency (TD) in men. Steroids. 2014 Oct; 88:106-16. PMID: 24942084; DOI: 10.1016/j.steroids.2014.05.010;

Traish AM. Outcomes of testosterone therapy in men with testosterone deficiency (TD): part II. Steroids. 2014 Oct; 88:117-26. PMID: 24863426; DOI: 10.1016/j.steroids.2014.05.004;

Kacker R, Morgentaler A, Traish A. Medical hypothesis: loss of the endocrine function of the prostate is important to the pathophysiology of postprostatectomy erectile dysfunction. J Sex Med. 2014 Aug; 11(8):1898-902. PMID: 24836599; DOI: 10.1111/jsm.12574;

Constantinou C, Mpatsoulis D, Natsos A, Petropoulou PI, Zvintzou E, Traish AM, Voshol PJ, Karagiannides I, Kypreos KE. The low density lipoprotein receptor modulates the effects of hypogonadism on diet-induced obesity and related metabolic perturbations. J Lipid Res. 2014 Jul; 55(7):1434-47. PMID: 24837748; PMCID: PMC4076071; DOI: 10.1194/jlr.M050047;

Morgentaler A, Traish A, Kacker R. Deaths and cardiovascular events in men receiving testosterone. JAMA. 2014 Mar 5; 311(9):961-2. PMID: 24595783; DOI: 10.1001/jama.2014.392;

Traish AM, Guay AT, Morgentaler A. Death by testosterone? We think not! J Sex Med. 2014 Mar; 11(3):624-9. PMID: 24589170; DOI: 10.1111/jsm.12464;

Haider A, Meergans U, Traish A, Saad F, Doros G, Lips P, Gooren L. Progressive Improvement of T-Scores in Men with Osteoporosis and Subnormal Serum Testosterone Levels upon Treatment with Testosterone over Six Years. Int J Endocrinol. 2014; 2014:496948.View Related Profiles.

Traish, Abdulmaged
Doros, Gheorghe

PMID: 24688541; PMCID: PMC3943258; DOI: 10.1155/2014/496948;

Kypreos KE, Zafirovic S, Petropoulou PI, Bjelogrlic P, Resanovic I, Traish A, Isenovic ER. Regulation of endothelial nitric oxide synthase and high-density lipoprotein quality by estradiol in cardiovascular pathology. J Cardiovasc Pharmacol Ther. 2014 May; 19(3):256-68. PMID: 24414281; DOI: 10.1177/1074248413513499;

Traish AM. Adverse Health Effects of Testosterone Deficiency (TD) in Men http://dx.doi.org/10.1016/j.steroids.2014.05.010. Steroids. 2014.
Traish AM. Outcomes of testosterone therapy in men with testosterone deficiency (TD):. Steroids. 2014.
Traish AM. Testosterone and Weight Loss: the Evidence. Current Opinion in Endocrinology and Diabetes. 2014.
Saad F, Haider A, Yassin A, Doros G, Traish AM. OBESE HYPOGONADAL MEN WITH TYPE 2 DIABETES LOSE WEIGHT AND ACHIEVE IMPROVED GLYCAEMIC CONTROL AND SEXUAL FUNCTION WHEN TREATED WITH TESTOSTERONE UNDECANOATE UP TO 6 YEARS: A SUBGROUP ANALYSIS FROM TWO OBSERVATIONAL REGISTRY STUDIES. Journal of Sexual Medicine. 2014; 11:7.
Saad F, Haider A, Doros G, Traish AM. Hypogonadal men with cardiovascular diseases benefit from long-term treatment with testosterone undecanoate: observational data from a registry study. 2014. View Publication
Yassin AA, Haider A, Zitzmann M, Saad F, Traish AM. Prostate Cancer Incidence in Hypogonadal Men on Long-Term Treatment with Testosterone Undecanoate Injections. Journal of Men s Health. 2014; 11(1):A11.
Saad F, Haider A, Yassin A, Traish AM. Meaningful and sustained weight loss and improvement of lipid profile in hypogonadal men on long-term treatment with testosterone undecanoate (TU) injections are independent of age: observational data from two registry studies. 2014. View Publication
Yassin A, Traish AM, Doros G, Saad F . 162 Hypogonadal Men with Obesity Respond to Long-Term Treatment with Testosterone Undecanoate with Unexpected Weight Loss. The Journal of Urology. 2014; 191(4):e336-e337. View Publication
Saad F, Haider A, Yassin AA, Doros G, Traish AM. Effects of Long-Term Treatment with Testosterone Undecanoate on Excessively Obese, Hypogonadal Men - An Observational Study. Journal of Men s Health. 2014; 11(1):A21.
Yassin A, Yassin DJ, Traish AM, Doros G, Saad F. Completing Five Years of Testosterone Treatment Leads to Progressive Weight Loss and Waist Size Reduction in Hypogonadal Men. The Journal of Urology. 2014; 191(4):e527. View Publication
Saad F, Haider A, Doros G, Traish AM. Improvement of Lipid Pattern, Insulin Resistance, and Blood Pressure in 300 Hypogonadal Men Treated with Testosterone Undecanoate Injections Up to 6 Years: an Update from a Registry Study. Journal of Men s Health. 2014; 11(1):A4.

Traish AM, Galoosian A. Androgens modulate endothelial function and endothelial progenitor cells in erectile physiology. Korean J Urol. 2013 Nov; 54(11):721-31. PMID: 24255752; PMCID: PMC3830963; DOI: 10.4111/kju.2013.54.11.721;

Traish AM, Haider A, Doros G, Saad F. Long-term testosterone therapy in hypogonadal men ameliorates elements of the metabolic syndrome: an observational, long-term registry study. Int J Clin Pract. 2014 Mar; 68(3):314-29.View Related Profiles.

Traish, Abdulmaged
Doros, Gheorghe

PMID: 24127736; PMCID: PMC4282282; DOI: 10.1111/ijcp.12319;

Isidori AM, Buvat J, Corona G, Goldstein I, Jannini EA, Lenzi A, Porst H, Salonia A, Traish AM, Maggi M. A critical analysis of the role of testosterone in erectile function: from pathophysiology to treatment-a systematic review. Eur Urol. 2014 Jan; 65(1):99-112. PMID: 24050791; DOI: 10.1016/j.eururo.2013.08.048;

Traish AM, Morgentaler A. Re: effect of finasteride on serum levels of androstenedione, testosterone and their 5a-reduced metabolites in men at risk for prostate cancer. J Steroid Biochem Mol Biol. 2013 Nov; 138:462. PMID: 23851167; DOI: 10.1016/j.jsbmb.2013.06.013;

Traish AM, Stottrup C, van Renterghem K, Achten R, Roy S. Density and distribution of connexin 43 in corpus cavernosum tissue from diabetic and hypogonadal patients with erectile dysfunction. Horm Mol Biol Clin Investig. 2013 Jun; 13(1):7-12.View Related Profiles.

Traish, Abdulmaged
Roy, Sayon

PMID: 25436709; DOI: 10.1515/hmbci-2013-0001;

Saad F, Haider A, Doros G, Traish A. Long-term treatment of hypogonadal men with testosterone produces substantial and sustained weight loss. Obesity (Silver Spring). 2013 Oct; 21(10):1975-81.View Related Profiles.

Traish, Abdulmaged
Doros, Gheorghe

PMID: 23512691; DOI: 10.1002/oby.20407;

Guay AT, Traish AM, Hislop-Chestnut DT, Doros G, Gawoski JM. Are there variances of calculated free testosterone attributed to variations in albumin and sex hormone-binding globulin concentrations in men? Endocr Pract. 2013 Mar-Apr; 19(2):236-42.View Related Profiles.

Traish, Abdulmaged
Doros, Gheorghe

PMID: 23543029; DOI: 10.4158/EP12113.OR;

Saad F, Yassin A, Doros G, Traish AM. Hypogonadal men receiving testosterone treatment for 5 years had significant and clinically meaningful reductions in weight and waist circumference. 2013. View Publication
Guay A, Garcia-Banigan D, Traish AM. RECURRENCE OF SEXUAL DYSFUNCTION IN A POSTMENOPAUSAL WOMAN ON ESTROGEN AND ANDROGEN REPLACEMENT TREATED WITH OXYCODONE. Journal of Sexual Medicine. 2013; 10:173.
Saad F, Haider A. Doros G, Traish AM. Obese hypogonadal men treated with testosterone undecanoate injections up to 5 years substantially and progressively lose weight. 2013. View Publication
Franzblau C, Broitman S, Moss M, Traish A, Romney C. Success of a Pre-medical Master's Degree Program in Preparing Students for Medical Careers . Procedia - Social and Behavioral Sciences,. 2013; 93(21):405-414.

Traish AM. 5a-reductases in human physiology: an unfolding story. Endocr Pract. 2012 Nov-Dec; 18(6):965-75. PMID: 23246684; DOI: 10.4158/12108.RA;

Yu G, Mylander C, Traish A, Jarrett T. Circulating levels of gonadotropins before and after prostate ablation in cancer patients. Horm Mol Biol Clin Investig. 2012 Oct; 11(3):355-62. PMID: 25436695; DOI: 10.1515/hmbci-2012-0027;

Kacker R, Traish AM, Morgentaler A. Estrogens in men: clinical implications for sexual function and the treatment of testosterone deficiency. J Sex Med. 2012 Jun; 9(6):1681-96. PMID: 22512993; DOI: 10.1111/j.1743-6109.2012.02726.x;

Traish AM, Miner MM, Morgentaler A, Zitzmann M. The reply. The American journal of medicine. 2012; 125(3):e7. View Publication
Saad F, Doros G, Traish A, Haider A. MOST HYPOGONADAL MEN ARE OBESE; LONG-TERM TESTOSTERONE TREATMENT LEADS TO CONTINUOUS AND SUSTAINED REDUCTIONS OF BODY WEIGHT AND WAIST CIRCUMFERENCE. Journal of Sexual Medicine. 2012; 9:365.

Traish AM, Kang HP, Saad F, Guay AT. Dehydroepiandrosterone (DHEA)--a precursor steroid or an active hormone in human physiology. J Sex Med. 2011 Nov; 8(11):2960-82; quiz 2983. PMID: 22032408; DOI: 10.1111/j.1743-6109.2011.02523.x;

Traish AM, Abdallah B, Yu G. Androgen deficiency and mitochondrial dysfunction: implications for fatigue, muscle dysfunction, insulin resistance, diabetes, and cardiovascular disease. Horm Mol Biol Clin Investig. 2011 Oct 1; 8(1):431-44. PMID: 25961343; DOI: 10.1515/HMBCI.2011.132;

Yu G, Traish AM. Induced testosterone deficiency: from clinical presentation of fatigue, erectile dysfunction and muscle atrophy to insulin resistance and diabetes. Horm Mol Biol Clin Investig. 2011 Oct 1; 8(1):425-30. PMID: 25961342; DOI: 10.1515/HMBCI.2011.131;

Bruelle C, Bédard M, Blier S, Gauthier M, Traish AM, Vincent M. The mitotic phosphorylation of p54(nrb) modulates its RNA binding activity. Biochem Cell Biol. 2011 Aug; 89(4):423-33. PMID: 21819346; DOI: 10.1139/O11-030;

Traish AM, Miner MM, Morgentaler A, Zitzmann M. Testosterone deficiency. Am J Med. 2011 Jul; 124(7):578-87. PMID: 21683825; DOI: 10.1016/j.amjmed.2010.12.027;

Wang C, Jackson G, Jones TH, Matsumoto AM, Nehra A, Perelman MA, Swerdloff RS, Traish A, Zitzmann M, Cunningham G. Low testosterone associated with obesity and the metabolic syndrome contributes to sexual dysfunction and cardiovascular disease risk in men with type 2 diabetes. Diabetes Care. 2011 Jul; 34(7):1669-75. PMID: 21709300; PMCID: PMC3120209; DOI: 10.2337/dc10-2339;

Guay AT, Traish A. Testosterone deficiency and risk factors in the metabolic syndrome: implications for erectile dysfunction. Urol Clin North Am. 2011 May; 38(2):175-83. PMID: 21621084; DOI: 10.1016/j.ucl.2011.02.004;

Traish AM, Kypreos KE. Testosterone and cardiovascular disease: an old idea with modern clinical implications. Atherosclerosis. 2011 Feb; 214(2):244-8. PMID: 20869058; DOI: 10.1016/j.atherosclerosis.2010.08.078;

Guay A, Traish AM, Hislop-Chestnut D, Doros G, Gawoski J. 36th Annual Meeting of Genes and Harmones. POTENTIAL VARIANCES OF CALCULATED FREE TESTOSTERONE (CFT) ATTRIBUTED TO VARIATIONS IN ALBUMIN (ALB) AND SEX HORMONE BINDING GLOBULIN (SHBG) CONCENTRATIONS. 2011; 8:54.
Yu G, Traish AM. Induced androgen deficiency: from clinical presentation to fatigue, erectile dysfunction and muscle atrophy to insulin resistance and diabetes. Hormones Molecular Biology and Clinical Investigations. 2011; 8:425-430.

Traish AM, Hassani J, Guay AT, Zitzmann M, Hansen ML. Adverse side effects of 5a-reductase inhibitors therapy: persistent diminished libido and erectile dysfunction and depression in a subset of patients. J Sex Med. 2011 Mar; 8(3):872-84. PMID: 21176115; DOI: 10.1111/j.1743-6109.2010.02157.x;

Traish AM. Role of androgens in modulating male and female sexual function. Horm Mol Biol Clin Investig. 2010 Dec 1; 4(1):521-8. PMID: 25961228; DOI: 10.1515/HMBCI.2010.052;

Guay A, Traish A. Testosterone therapy in women with androgen deficiency: Its time has come. Curr Opin Investig Drugs. 2010 Oct; 11(10):1116-26. PMID: 20872314

Traish AM, Botchevar E, Kim NN. Biochemical factors modulating female genital sexual arousal physiology. J Sex Med. 2010 Sep; 7(9):2925-46. PMID: 20626599; DOI: 10.1111/j.1743-6109.2010.01903.x;

Traish AM, Gooren LJ. Safety of physiological testosterone therapy in women: lessons from female-to-male transsexuals (FMT) treated with pharmacological testosterone therapy. J Sex Med. 2010 Nov; 7(11):3758-64. PMID: 20722789; DOI: 10.1111/j.1743-6109.2010.01962.x;

Traish AM, Fetten K, Miner M, Hansen ML, Guay A. Testosterone and risk of breast cancer: appraisal of existing evidence. Horm Mol Biol Clin Investig. 2010 Aug 1; 2(1):177-90. PMID: 25961191; DOI: 10.1515/HMBCI.2010.024;

Morgentaler A, Rhoden EL, Guay A, Traish A. Serum testosterone is associated with aggressive prostate cancer in older men: results from the Baltimore Longitudinal Study of Aging. BJU Int. 2010 Mar; 105(6):884-5; author reply 885-6. PMID: 20353537; DOI: 10.1111/j.1464-410X.2010.09277_1.x;

Traish AM. Role of androgens in modulating male and female sexual function. Horm Mol Biol Clin Invest. 2010; 4:521-528.
Traish AM, Fetten K, Miner M, Hansen M, Guay AT. Testosterone and Risk of Breast Cancer: Appraisal of the Existing Evidence. Hormone Molecular Biology and Clinical Investigation. 2010; 2:177-190.
Traish AM, Hassani J, Guay AT, Zitzmann M, Lutzhoft Hansen M. 5a-Reductase inhibitor therapy: Should physicians be concerned with persistent diminished libido, erectile dysfunction and depression in a subset of patients?. Journal of Men s Health. 2010; 7(3):307. View Publication

Traish AM, Morgentaler A. Epidermal growth factor receptor expression escapes androgen regulation in prostate cancer: a potential molecular switch for tumour growth. Br J Cancer. 2009 Dec 15; 101(12):1949-56. PMID: 19888222; PMCID: PMC2795439; DOI: 10.1038/sj.bjc.6605376;

Traish AM, Abdou R, Kypreos KE. Androgen deficiency and atherosclerosis: The lipid link. Vascul Pharmacol. 2009 Nov-Dec; 51(5-6):303-13. PMID: 19818414; DOI: 10.1016/j.vph.2009.09.003;

Guay A, Seftel AD, Traish A. Hypogonadism in men with erectile dysfunction may be related to a host of chronic illnesses. Int J Impot Res. 2010 Jan-Feb; 22(1):9-19. PMID: 19798059; DOI: 10.1038/ijir.2009.46;

Traish AM, Feeley RJ, Guay A. Mechanisms of obesity and related pathologies: androgen deficiency and endothelial dysfunction may be the link between obesity and erectile dysfunction. FEBS J. 2009 Oct; 276(20):5755-67. PMID: 19754871; DOI: 10.1111/j.1742-4658.2009.07305.x;

Feeley RJ, Traish AM. Obesity and erectile dysfunction: is androgen deficiency the common link? ScientificWorldJournal. 2009; 9:676-84. PMID: 19649506; PMCID: PMC5823217; DOI: 10.1100/tsw.2009.79;

Cushman TT, Kim N, Hoyt R, Traish AM. Estradiol ameliorates diabetes-induced changes in vaginal structure of db/db mouse model. J Sex Med. 2009 Sep; 6(9):2467-79.View Related Profiles.

Traish, Abdulmaged
Hoyt, Richard

PMID: 19453883; DOI: 10.1111/j.1743-6109.2009.01316.x;

Traish AM, Saad F, Feeley RJ, Guay A. The dark side of testosterone deficiency: III. Cardiovascular disease. J Androl. 2009 Sep-Oct; 30(5):477-94. PMID: 19342698; DOI: 10.2164/jandrol.108.007245;

Munarriz R, Traish AM. Impact Of Androgen Deprivation On Male Sexual Function. Sexual Function in the Prostate Cancer Patient; Edited by John P. Mulhall. Humana Press Series: Current Clinical Urology. Totowa, New Jersey. 2009.

Cushman T, Kim N, Hoyt R, Traish AM. Estradiol restores diabetes-induced reductions in sex steroid receptor expression and distribution in the vagina of db/db mouse model. J Steroid Biochem Mol Biol. 2009 Apr; 114(3-5):186-94.View Related Profiles.

Traish, Abdulmaged
Hoyt, Richard

PMID: 19429450; DOI: 10.1016/j.jsbmb.2009.01.023;

Traish AM, Cushman T, Hoyt R, Kim N. Diabetes Attenuates Female Genital Sexual Arousal Response via Disruption of Estrogen Action. Korean journal of urology. 2009; 50(3). View Publication
Guay AT, Traish AM. Psychological as well as medical conditions are associated with a high prevalence of hypogonadism. American journal of men's health. 2009; 6(3):237. View Publication
Morgentaler A, Traish AM. Reply to A. Edward Friedman’s Letter to the Editor re: Abraham Morgentaler, Abdulmaged M. Traish. Shifting the Paradigm of Testosterone and Prostate Cancer: The Saturation Model and the Limits of Androgen-Dependent Growth. Eur Urol. 2009; 55:310-321.
Feeley RJ, Saad F, Guay AT, Traish AM. Testosterone in Men’s Health: A New Role for an Old Hormone. Journal of Men’s Health. 2009; 6:169-176.
Traish AM, Cushman T, Hoyt R, Kim NN. Female Genital Sexual Arousal Dysfunction in Diabetes: The Estrogen Link. Korean J. Urology. 2009; 50:211-223.
Traish AM, Saad F. Is there a place for androgen therapy in sexual medicine? Current approaches and future developments. Research Signpost 37/661 (2), Fort P.O., Trivandrum-695 023, Kerala, India. Advances in Sexual Medicine: Drug Discovery Issues, Editor: Ibrahim A. Abdel-Hamid. 2009.
Guay AT, Traish AM. The Clinical Picture of Adult Male Hypogonadism: A Case-Based Approach. Medscape Education Urology. 2009. View Publication
Yassin AA, Traish AM. BPH-associated sexual dysfunction: Etiology & Pathogenesis: An organic point of view. American journal of men's health. 2009; 6(3):262. View Publication
Yassin AA, Traish AM. Erectile dysfunction and LUTS at the cellular level: Impact of Aging and/or Hypogonadism on Prostate & Cavernosal Tissues. American journal of men's health. 2009; 6(3):261. View Publication
Saad F, Traish AM, Yassin A, Kalinchenko S, Shabsigh R. The Metabolic Syndrome and Erectile Dysfunction: testosterone may be a common denominator. American journal of men's health. 2009; 6(3):259. View Publication

Traish AM, Feeley RJ, Guay AT. Testosterone therapy in women with gynecological and sexual disorders: a triumph of clinical endocrinology from 1938 to 2008. J Sex Med. 2009 Feb; 6(2):334-51. PMID: 19138368; DOI: 10.1111/j.1743-6109.2008.01121.x;

Carruthers M, Trinick TR, Jankowska E, Traish AM. Are the adverse effects of glitazones linked to induced testosterone deficiency? Cardiovasc Diabetol. 2008; 7:30. PMID: 18922158; PMCID: PMC2576082; DOI: 10.1186/1475-2840-7-30;

Morgentaler A, Traish AM. Shifting the paradigm of testosterone and prostate cancer: the saturation model and the limits of androgen-dependent growth. Eur Urol. 2009 Feb; 55(2):310-20. PMID: 18838208; DOI: 10.1016/j.eururo.2008.09.024;

Traish AM. Androgens play a pivotal role in maintaining penile tissue architecture and erection: a review. J Androl. 2009 Jul-Aug; 30(4):363-9. PMID: 18802199; DOI: 10.2164/jandrol.108.006007;

Traish AM, Saad F, Guay A. The dark side of testosterone deficiency: II. Type 2 diabetes and insulin resistance. J Androl. 2009 Jan-Feb; 30(1):23-32. PMID: 18772488; DOI: 10.2164/jandrol.108.005751;

Traish AM, Guay A, Feeley R, Saad F. The dark side of testosterone deficiency: I. Metabolic syndrome and erectile dysfunction. J Androl. 2009 Jan-Feb; 30(1):10-22. PMID: 18641413; DOI: 10.2164/jandrol.108.005215;

Kurbatov D, Kuznetsky J, Traish A. Testosterone improves erectile function in hypogonadal patients with venous leakage. J Androl. 2008 Nov-Dec; 29(6):630-7. PMID: 18599885; DOI: 10.2164/jandrol.108.005264;

Traish A, Kim N. Is vardenafil "noninferior" or superior to sildenafil in the management of erectile dysfunction? Revisiting the biochemical, physiological, and clinical evidence. J Sex Med. 2008 Jul; 5(7):1762-8; discussion 1768-9. PMID: 18221281; DOI: 10.1111/j.1743-6109.2007.00719.x;

Guay AT, Traish AM. Testosterone therapy and breast cancer? Fertil Steril. 2008 Aug; 90(2):468; author reply 468-9. PMID: 18585711; DOI: 10.1016/j.fertnstert.2008.05.062;

Guay AT, Traish AM. Impact of the Metabolic Syndrome on Erectile Dysfunction. Current Sexual Health Reports. 2008; 5:163–167.

Traish AM, Abu-Zahra H, Guay AT. The brain, the penis and steroid hormones: clinical correlates with endothelial dysfunction. Curr Pharm Des. 2008; 14(35):3723-36. PMID: 19128225

Brugger N, Kim NN, Araldi GL, Traish AM, Palmer SS. Pharmacological and functional characterization of novel EP and DP receptor agonists: DP1 receptor mediates penile erection in multiple species. J Sex Med. 2008 Feb; 5(2):344-56. PMID: 18047485

Traish AM , Guay A. The Authors' Response to Guidelines Panel's Comments. J Sex Med. 2007; 4(6):1784-1785.

Traish A, Guay AT, Spark RF. Are the Endocrine Society's Clinical Practice Guidelines on Androgen Therapy in Women misguided? A commentary. J Sex Med. 2007 Sep; 4(5):1223-34; discussion 1234-5. PMID: 17727347

Traish AM, Kim SW, Stankovic M, Goldstein I, Kim NN. Testosterone increases blood flow and expression of androgen and estrogen receptors in the rat vagina. J Sex Med. 2007 May; 4(3):609-19. PMID: 17498100

Traish AM, Goldstein I, Kim NN. Testosterone and erectile function: from basic research to a new clinical paradigm for managing men with androgen insufficiency and erectile dysfunction. Eur Urol. 2007 Jul; 52(1):54-70. PMID: 17329016; PMCID: PMC2562639; DOI: 10.1016/j.eururo.2007.02.034;

Traish AM. Study of interstitial cells in the penis: Human study - Commentary. Journal of Sexual Medicine. 2007; 4(1):70-71.

Kim NN, Stankovic M, Armagan A, Cushman TT, Goldstein I, Traish AM. Effects of tamoxifen on vaginal blood flow and epithelial morphology in the rat. BMC Womens Health. 2006; 6:14. PMID: 16970814; PMCID: PMC1590006; DOI: 10.1186/1472-6874-6-14;

Munarriz R, Wen CC, McAuley I, Goldstein I, Traish A, Kim N. Management of ischemic priapism with high-dose intracavernosal phenylephrine: from bench to bedside. J Sex Med. 2006 Sep; 3(5):918-22.View Related Profiles.

Year	Publications
1980	4
1981	2
1982	2
1983	2
1984	2
1985	6
1986	3
1987	2
1988	1
1989	2
1990	4
1991	5
1992	4
1994	5
1995	8
1996	6
1997	6
1998	12
1999	7
2000	12
2001	9
2002	13
2003	13
2004	15
2005	6
2006	15
2007	6
2008	11
2009	19
2010	10
2011	10
2012	5
2013	11
2014	23
2015	16
2016	11
2017	15
2018	14
2019	4
2020	4
2021	4
2022	1
2023	1